Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins Jim Cramers PreCrash Comments on Intuit What Investors Should Know Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Performance Why Taiwan Became the Defining Issue in TrumpXi Talks Implications for Global Markets Stock Trades Disclosed by Trump Draw Scrutiny from Ethics Experts Ferraris Luce EV Enters Luxury Electric Segment Amid Market Uncertainties BJs Wholesale to Revamp Stores Amid Consumer Spending Shift